Immune reconstitution and tolerance-inducing therapies as promising therapeutic approaches in multiple sclerosis
This review reframes MS immunotherapy through a tolerance-centric paradigm, distinguishing continuous maintenance disease-modifying therapies (DMTs) from immune reconstitution therapies (IRTs) from immune reconstitution therapies (IRTs) and emerging antigen-specific tolerance strategies.